Tag: Eli Lilly
FDA Oversight Issues Highlighted by Eli Lilly Weight Loss Drug Shortage
The recent shortage of Eli Lilly's popular weight loss drug has brought to light some concerns about how the Food and Drug Administration manages drug shortages and where it gets its information. This issue...
Senators Seek Clarity on Pfizer and Eli Lilly’s Telehealth Platforms
Senators, including Sen. Dick Durbin, are calling on Pfizer and Eli Lilly to provide more information about their partnerships with telehealth providers. These pharmaceutical companies recently launched websites that offer users information about their...
FDA Reconsiders Removing Eli Lilly Weight Loss Drug from Shortage List
The Food and Drug Administration, or FDA, announced on Friday that it would be revisiting its decision to remove Eli Lilly's tirzepatide, which is known as Mounjaro for diabetes and Zepbound for obesity, from...
Patients caught in middle of Eli Lilly and compounders weight loss drug battle
The battle over blockbuster weight loss medications is intensifying, and patients are finding themselves caught in the middle. The Food and Drug Administration recently announced the end of the shortage of Eli Lilly's tirzepatide,...